Blockade of the monocyte chemoattractant protein-1 receptor pathway ameliorates myocardial injury in animal models of ischemia and reperfusion

Pharmacology

Volumn 93, Issue 5-6, 2014, Pages 296-302

  Al Amran, Fadhil G ^a   Manson, Mandel Z ^b   Hanley, Tennent K ^b   Hainz, Douglas L ^b  

^a UNIVERSITY OF KUFA   (Iraq)

^b The Australian National University   (Australia)

Author keywords

Apoptosis; Ischemia reperfusion; Left anterior descending coronary artery; Monocyte chemoattractant protein 1

Indexed keywords

CASPASE 3; CASPASE 7; CASPASE 8; CHEMOKINE RECEPTOR CCR2 ANTAGONIST; CASPASE; CCL2 PROTEIN, MOUSE; MONOCLONAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; COMPLEMENT DEPOSITION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ENZYME ACTIVITY; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; IMMUNOHISTOCHEMISTRY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MOUSE; MYOCARDITIS; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; HEART MUSCLE; METABOLISM; MYOCARDIAL REPERFUSION INJURY; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; ANTIBODIES, MONOCLONAL; APOPTOSIS; CASPASES; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; MALE; MICE, INBRED C57BL; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; VENTRICULAR FUNCTION, LEFT;

EID: 84906605908     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000363657     Document Type: Article

References (29)

1. Yousif NG, Ao L, Cleveland JC, Fullerton DA, Meng X: Aging augments myocardial inflammatory response to ischemia and reperfusion: an obligatory role of TLR-4. Shock 2012; 37: 32.
2. Ylä-Herttuala S, Lipton BA, Rosenfeld ME, Särkioja T, Yoshimura T, Leonard EJ, Witztum JL, Steinberg D: Expression of monocyte chemoattractant protein 1 in macrophagerich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 1991; 88: 5252-5256.
3. Wilenky JH, Chang H, Kam JA, Martins WD: Daytime peak incidence of death due to the ischemic heart disease. Am J BioMedicine 2013; 2: 255-269.
4. Weber C, Schober A, Zernecke A: Chemokines: key regulators of mononuclear cell recruitment in atherosclerotic vascular disease. Arterioscler Thromb Vasc Biol 2004; 24: 1997-2008.
5. Göser S, Ottl R, Brodner A, Dengler TJ, Torzewski J, Egashira K, Rose NR, Katus HA, Kaya Z: Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1? in induction of experimental autoimmune myocarditis and effective anti-MCP-1 gene therapy. Circulation 2005; 112: 3400-3407.
6. Aukrust P, Ueland T, Müller F, Andreassen AK, Nordøy I, Aas H, Kjekshus J, Simonsen S, Frøland SS, Gullestad L: Elevated circulating levels of C-C chemokines in patients with congestive heart failure. Circulation 1998; 97: 1136-1143.
7. Behr TM, Wang X, Aiyar N, Coatney RW, Li X, Koster P, Angermann CE, Ohlstein E, Feuerstein GZ, Winaver J: Monocyte chemoattractant protein-1 is upregulated in rats with volume-overload congestive heart failure. Circulation 2000; 102: 1315-1322.
8. Charo IF, Taubman MB: Chemokines in the pathogenesis of vascular disease. Circ Res 2004; 95: 858-866.
9. Boldron J, Caltabiano S, Debono SD, Thompson R, Scammells M, Westover R, Wu Y, Frugier P: Adhesion molecule expression trigger immune-mediated pathology in lupus-nephritis. Am J BioMedicine 2013; 1: 49-57.
10. Oguchi S, Dimayuga P, Zhu J, Chyu KY, Yano J, Shah PK, Nilsson J, Cercek B: Monoclonal antibody against vascular cell adhesion molecule-inhibits neointimal formation after periadventitial carotid artery injury in genetically hypercholesterolemic mice. Arterioscler Thromb Vasc Biol 2000; 20: 1729-1736.
11. Ni W, Egashira K, Kitamoto S, Kataoka C, Koyanagi M, Inoue S, Imaizumi K, Akiyama C, Nishida KI, Takeshita A: New anti-monocyte chemoattractant protein-1 gene therapy attenuates atherosclerosis in apolipoprotein E-knockout mice. Circulation 2001; 103: 2096-2101.
12. Guo J, Van Eck M, Twisk J, Maeda N, Benson GM, Groot PH, Van Berkel TJ: Transplantation of monocyte CC-chemokine receptor 2-deficient bone marrow into ApoE3-Leiden mice inhibits atherogenesis. Arterioscler Thromb Vasc Biol 2003; 23: 447-453.
13. Ramote D, Kishony J, Bren L: Role of monocyte chemoattractant protein-1 (MCP-1) in atherosclerosis: signature of monocytes and macrophages. Am J BioMedicine 2014; 2: 67-79.
14. Kruglov EA, Nathanson RA, Nguyen T, Dranoff JA: Secretion of MCP-1/CCL2 by bile duct epithelia induces myofibroblastic transdifferentiation of portal fibroblasts. Am J Physiol Gastrointest Liver Physiol 2006; 290:G765-G771.
15. Yousif NG: Fibronectin promotes migration and invasion of ovarian cancer cells through up-regulation of FAK-PI3K/Akt pathway. Cell Biol Int 2014; 38: 85-91.
16. Michael LH, Entman ML, Hartley CJ, Youker KA, Zhu J, Hall SR, Hawkins HK, Berens K, Ballantyne CM: Myocardial ischemia and reperfusion: a murine model. Am J Physiol 1995; 269:H2147-H2154.
17. Ha T, Hu Y, Liu L, Lu C, McMullen JR, Shioi T, et al: TLR2 ligands induce cardioprotection against ischemia/reperfusion injury through a PI3K/Akt-dependent mechanism. Cardiovasc Res 2010; 87: 694-703.
18. Zhang R, Singh S, Ha X, Cowsik G, Lavezzi O, Caudell H, Ohura R: TLR3 exaggerated sepsis induced cardiac dysfunction via activation of TLR4-mediated NF-?B and TRIF/IRF signaling pathways. Am J BioMedicine 2014; 2: 94-112.
19. Hua F, Ha T, Ma J, Li Y, Kelley J, Gao X, et al: Protection against myocardial ischemia/reperfusion injury in TLR4 deficient mice is mediated through a phosphoinositide 3-kinase dependent mechanism. J Immunol 2007; 178: 7317-7324.
20. Li C, Ha T, Kelley J, Gao X, Qiu Y, Kao RL, et al: Modulating Toll-like receptor mediated signaling by (1 ? 3)-?-D-glucan rapidly induces cardioprotection. Cardiovasc Res 2003; 61: 538-547.
21. Kaikita K, Hayasaki T, Okuma T, Kuziel WA, Ogawa H, Takeya M: Targeted deletion of CC chemokine receptor 2 attenuates left ventricular remodeling after experimental myocardial infarction. Am J Pathol 2004; 165: 439-447.
22. Austin EW, Yousif NG, Ao L, Cleveland JC, Fullerton DA, Meng X: Ghrelin reduces myocardial injury following global ischemia and reperfusion via suppression of myocardial inflammatory response. Am J BioMedicine 2013; 1: 38-48.
23. Bracale MM, Wonderge RB, Zhou M, Hazen EG: Endotoxemia-suppress cardiac function through dysregulation of mitochondrial biogenesis in mice model. Am J BioMedicine 2014; 2: 323-336.
24. Kaya Z, Dohmen KM, Wang Y, Schlichting J, Afanasyeva M, Leuschner F, Rose NR: Cutting edge: a critical role for IL-10 in induction of nasal tolerance in experimental autoimmune myocarditis. J Immunol 2002; 168: 1552-1556.
25. Yousif NG, Al-Amran FG: Novel Toll-like receptor-deficiency attenuates trastuzumab (Herceptin) induced cardiac injury in mice. BMC Cardiovasc Disord 2011; 11: 62.
26. Inoshima I, Kuwano K, Hamada N, Hagimoto N, Yoshimi M, Maeyama T, Takeshita A, Kitamoto S, Egashira K, Hara N: Antimonocyte chemoattractant protein-1 gene therapy attenuates pulmonary fibrosis in mice. Am J Physiol Lung Cell Mol Physiol 2004; 286:L1038-L1044.
27. Steg J, Slimani H, Hanley TK, Pearson BD, Manson MZ: Directs role of CRP in promoting pathogenesis of atherosclerosis through up-regulation of proinflammatory cytokines. Am J BioMedicine 2014; 2: 238-244.
28. Yousif NG, Ao L, Li J, Aly A, Austin E, Fullerton DA, Meng X: Myocardial tissue TLR4 plays a major role in mediating myocardial injury following cold ischemia and reperfusion through up-regulation of MCP-1. J Surg Res 2012; 165: 181.
29. Matsuda S, Nakamura J, Eikan S, Meier R, Katz K, Richter J, Mazzon D: XIAP expression attenuated myocardial injury in aging hearts after myocardial ischemia and reperfusion in mice model. Am J BioMedicine 2014; 2: 400-421.